Apellis Pharmaceuticals, Inc. ($APLS)
Filing Information
| Accession Number | 0001492422-26-000077 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 30, 2026 |
| Document Date | Jan 28, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
36,606
Total Value
$0.00
P&L
+inf% (+$629,989.26)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Business & Strat Officer | Common Stock | โ | Jan 28, 2026 | Grant/Award | 36,606 | $0.00 | $0.00 | 114,959 | Direct | โ | View Details |